Sarepta Therapeutics Inc. (srpt 1.5 11/15/24)
13F holders, Q1 2024 (March 31)3holders
$1.79avg. 13F price*
At the end of Q1 2024, 3 institutions reported holding Sarepta Therapeutics Inc. (srpt 1.5 11/15/24) in their 13F filings. The largest holders were Boothbay Fund Management, LLC ($6.3M), Fox Hill Wealth Management ($43K) and Northwestern Mutual Wealth Management Co. ($4K).
- Company
- Sarepta Therapeutics Inc. (srpt 1.5 11/15/24)
- CUSIP
- 803607AB6
- Latest filing quarter
- Q3 2024
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 2 | $6K |
Ownership 3 holders
| Boothbay Fund Management, LLC | 0.20% | Add +74.3% | 3,512,000 | $6.3M |
| Fox Hill Wealth Management | 0.03% | Add +4.3% | 24,000 | $43K |
| Northwestern Mutual Wealth Management Co. | 0.00% | No change | 2,000 | $4K |
"% of holder's portfolio" is SAREPTA THERAPEUTICS INC (SRPT 1.5 11/15/24)'s weight in each manager's 13F, not the share of Sarepta Therapeutics Inc. (srpt 1.5 11/15/24) the manager owns.